# Repaglinide

NDC: 72603-812
Generic name: Repaglinide
Labeler / Manufacturer: NorthStar RxLLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250408

FDA application: ANDA207209

## Active ingredients

- REPAGLINIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-812"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-812
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665